Nucleotide expression systems with reduced immunogenicity...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/86 (2006.01) A61K 38/16 (2006.01) A61K 48/00 (2006.01) C12N 5/10 (2006.01) C12N 15/34 (2006.01) C12N 15/38 (2006.01)

Patent

CA 2318664

This invention suppresses the immune response to viral or non-viral based methods of gene delivery by incorporating immunosuppressive genes within the gene delivery system. These immunosuppressive genes may be used in addition to a therapeutic treatment or as a therapeutic treatment by themselves.

La présente invention concerne un procédé permettant la suppression de la réponse immunitaire en cas d'introduction de gènes selon des techniques de type virales ou non virales. A cet effet, on incorpore des gènes d'immuno-dépression dans le système d'introduction des gènes. Ces gènes d'immuno-dépression peuvent s'utiliser en complément d'un traitement thérapeutique ou directement comme traitement thérapeutique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Nucleotide expression systems with reduced immunogenicity... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleotide expression systems with reduced immunogenicity..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleotide expression systems with reduced immunogenicity... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1598753

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.